Best MRgFUS Hospitals in Israel

At Rabin Medical Center, MRgFUS is performed using advanced MRI-guided focused ultrasound technology and personalised treatment protocols based on the patient's condition and treatment goals. Established in 1996, this JCI hospital in Petah Tikva, Israel has 1300 beds and provides comprehensive image-guided treatment services.

MRgFUS uses focused ultrasound waves to deliver energy to a precisely defined target without requiring a conventional surgical incision. MRI is used to identify the treatment area, guide the procedure, and monitor tissue temperature during treatment. The technique may be considered for appropriately selected patients with conditions such as symptomatic uterine fibroids or certain movement disorders. Detailed imaging and medical assessment are performed in advance to determine whether the target can be treated safely and effectively.

Choosing Sheba Medical Center for MRgFUS gives patients access to advanced MRI-guided treatment technology, experienced specialists, and coordinated clinical care. Established in 1948, the JCI hospital in Ramat Gan, Israel has 1900 beds and provides specialized image-guided treatment services.

MRgFUS may be considered for selected patients when a precisely localised treatment target can be safely accessed using focused ultrasound. During the procedure, MRI provides continuous visualisation and allows clinicians to monitor treatment-related temperature changes, while ultrasound energy is concentrated at the target. Depending on the condition, MRgFUS can be used for tissue ablation or therapeutic modulation without the need for conventional surgical access. Patient selection depends on factors such as the diagnosis, target location, anatomy, imaging findings, and overall health.

Kaplan Medical Centre is a trusted healthcare provider for MRgFUS, offering specialised image-guided treatment supported by experienced radiologists, neurologists, gynecologists, and other relevant specialists. Established in 1953, the JCI hospital is situated in Rehovot, Israel and has 1100 beds.

MRgFUS (Magnetic Resonance-Guided Focused Ultrasound) is a non-invasive technology that uses MRI guidance and focused ultrasound energy to treat a specific tissue target. The MRI system helps physicians visualise the anatomy and monitor temperature changes during energy delivery. Depending on the indication, the treatment can be used to ablate selected tissue or modify targeted neural pathways. Before treatment, imaging and clinical evaluation are performed to confirm suitability, define the target, and assess surrounding structures.

At Assuta Hospital, MRgFUS is performed using advanced MRI-guided focused ultrasound technology and personalised treatment protocols based on the patient's condition and treatment goals. Established in 1934, this JCI hospital in Tel Aviv, Israel has 300 beds and provides comprehensive image-guided treatment services.

MRgFUS uses focused ultrasound waves to deliver energy to a precisely defined target without requiring a conventional surgical incision. MRI is used to identify the treatment area, guide the procedure, and monitor tissue temperature during treatment. The technique may be considered for appropriately selected patients with conditions such as symptomatic uterine fibroids or certain movement disorders. Detailed imaging and medical assessment are performed in advance to determine whether the target can be treated safely and effectively.

At Tel Aviv Sourasky Medical Center -Ichilov Hospital, MRgFUS is performed using advanced MRI-guided focused ultrasound technology and personalised treatment protocols based on the patient's condition and treatment goals. Established in 1963, this JCI hospital in Tel Aviv, Israel has 1500 beds and provides comprehensive image-guided treatment services.

MRgFUS uses focused ultrasound waves to deliver energy to a precisely defined target without requiring a conventional surgical incision. MRI is used to identify the treatment area, guide the procedure, and monitor tissue temperature during treatment. The technique may be considered for appropriately selected patients with conditions such as symptomatic uterine fibroids or certain movement disorders. Detailed imaging and medical assessment are performed in advance to determine whether the target can be treated safely and effectively.